Merck is the famous Corporate Investor, which was founded in 1891. The leading representative office of defined Corporate Investor is situated in the Kenilworth. The venture was found in North America in United States.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Merck, startups are often financed by Tichenor Ventures, Skyline Ventures, SV Health Investors. The meaningful sponsors for the fund in investment in the same round are ARCH Venture Partners, Lilly Asia Ventures, Bill & Melinda Gates Foundation. In the next rounds fund is usually obtained by Lilly Asia Ventures, ARCH Venture Partners, Temasek Holdings.
Among the most popular fund investment industries, there are Health Diagnostics, Medical. Among the most popular portfolio startups of the fund, we may highlight Moderna Therapeutics, NGM Biopharmaceuticals, GenomeDx Biosciences. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 2 of the founder, the probability for it to get the investment is little.
The average startup value when the investment from Merck is 500 millions - 1 billion dollars. The top activity for fund was in 2016. The increased amount of exits for fund were in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this Corporate Investor is 2 percentage points less often commits exit comparing to other companies. This Merck works on 6 percentage points more the average amount of lead investments comparing to the other organizations. The fund is constantly included in less than 2 investment rounds annually.
The current fund was established by George W. Merck. We also calculated 2 valuable employees in our database.
| Fund Name | Location |
| Enabling Future | Dubai, United Arab Emirates |
| GAIN | Gujarat, India, Vadodara |
| Japan Research Institute | Chiyoda, Japan |
| Lloyds Bank | England, London, United Kingdom |
| LNC Partners | District of Columbia, United States, Washington |
| Multicroissance | Balma, France, Midi-Pyrenees |
| P2P Capital | - |
| Sealed Air Corporation | Elmwood Park, New Jersey, United States |
| Uzabase | Chiyoda, Japan |
| Yangyin Touzi | China, Fujian, Xiamen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Aktis Oncology | $84M | 25 Aug 2022 | Boston, Massachusetts, United States | ||
Orna Therapeutics | $221M | 16 Aug 2022 | Cambridge, Massachusetts, United States | ||
Legendairy Foods | $4M | 19 Dec 2019 | Berlin, Berlin, Germany | ||
| $25K | 15 Sep 2016 | Eindhoven, North Brabant, Netherlands | |||
| $10M | 07 Feb 2008 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Aktis Oncology | $84M | 25 Aug 2022 | Boston, Massachusetts, United States | ||
Orna Therapeutics | $221M | 16 Aug 2022 | Cambridge, Massachusetts, United States | ||
Legendairy Foods | $4M | 19 Dec 2019 | Berlin, Berlin, Germany | ||
| $25K | 15 Sep 2016 | Eindhoven, North Brabant, Netherlands | |||
| $10M | 07 Feb 2008 | San Diego, California, United States |
